Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D T Barrett

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2012
Editorial commentary. Short-course oral corticosteroid therapy is not effective in early dengue infectionAlan D T Barrett
Journal of Travel Medicine|October 6, 2018
West Nile in Europe: an increasing public health problemAlan D T Barrett
The New England Journal of Medicine|June 9, 2016
Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and DemandAlan D T Barrett
The Journal of Infectious Diseases|September 24, 2019
Yellow Fever Vaccine: The Conundrum of 2 Doses, One Dose, or One-Fifth Dose to Induce and Maintain Protective ImmunityAlan D T Barrett
Expert Review of Vaccines|July 24, 2004
Current status of the Arilvax; yellow fever vaccineAlan D T Barrett
NPJ Vaccines|June 15, 2018
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluationAlan D T Barrett
Annual Review of Entomology|August 18, 2006
Yellow fever: a disease that has yet to be conqueredAlan D T Barrett, Stephen Higgs
Virology|August 28, 2007
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virusGregory D Gromowski, Alan D T Barrett
Cell Host & Microbe|May 15, 2020
Finding Their Type: Elusive Antigenic Sites on Dengue Virus 3 Mapped with Human AntibodiesVanessa V Sarathy, Alan D T Barrett
Nature Reviews. Microbiology|September 21, 2004
Transmission cycles, host range, evolution and emergence of arboviral diseaseScott C Weaver, Alan D T Barrett
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2012
Editorial commentary. Short-course oral corticosteroid therapy is not effective in early dengue infectionAlan D T Barrett
Journal of Travel Medicine|October 6, 2018
West Nile in Europe: an increasing public health problemAlan D T Barrett
The New England Journal of Medicine|June 9, 2016
Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and DemandAlan D T Barrett
The Journal of Infectious Diseases|September 24, 2019
Yellow Fever Vaccine: The Conundrum of 2 Doses, One Dose, or One-Fifth Dose to Induce and Maintain Protective ImmunityAlan D T Barrett
Expert Review of Vaccines|July 24, 2004
Current status of the Arilvax; yellow fever vaccineAlan D T Barrett
NPJ Vaccines|June 15, 2018
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluationAlan D T Barrett
Annual Review of Entomology|August 18, 2006
Yellow fever: a disease that has yet to be conqueredAlan D T Barrett, Stephen Higgs
Virology|August 28, 2007
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virusGregory D Gromowski, Alan D T Barrett
Cell Host & Microbe|May 15, 2020
Finding Their Type: Elusive Antigenic Sites on Dengue Virus 3 Mapped with Human AntibodiesVanessa V Sarathy, Alan D T Barrett
Nature Reviews. Microbiology|September 21, 2004
Transmission cycles, host range, evolution and emergence of arboviral diseaseScott C Weaver, Alan D T Barrett
Pageof 20